tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market

Jazz Pharmaceuticals (JAZZ) Income Statement

Compare
1,550 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q3 2024), Jazz Pharmaceuticals's total revenue was $1.05B, an increase of 8.52% from the same quarter last year. In Q3, Jazz Pharmaceuticals's net income was $215.06M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.83B$ 3.66B$ 3.09B$ 2.36B$ 2.16B
Gross Profit
$ 3.40B$ 3.12B$ 2.65B$ 2.21B$ 2.03B
Operating Expenses
$ 2.82B$ 2.61B$ 2.48B$ 1.45B$ 1.39B
Depreciation and Amortization
$ 638.70M$ 629.47M$ 552.48M$ 278.25M$ 370.16M
EBITDA
$ 1.23B$ 553.78M$ 1.03B$ 649.65M$ 1.01B
Operating Income
$ 578.58M$ 512.27M$ 170.28M$ 765.46M$ 532.37M
Other Income/Expenses
$ -280.65M$ -307.26M$ -283.12M$ -102.98M$ -78.07M
Pretax Income
$ 297.93M$ -372.78M$ -112.84M$ 275.10M$ 454.30M
Net Income
$ 414.83M$ -214.14M$ -328.95M$ 238.62M$ 523.37M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 6.95$ -3.42$ -5.51$ 4.28$ 9.22
Diluted EPS
$ 6.10$ -3.42$ -5.51$ 4.22$ 9.09
Weighted Average Shares Outstanding
63.29M 62.54M 59.69M 55.71M 56.75M
Weighted Average Shares Outstanding (Diluted)
72.07M 62.54M 59.69M 56.52M 57.55M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis